Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World

The U.S. must assess its pricing and reimbursement system for prescription drugs. The current system is attracting intense scrutiny for various reasons. Drug pricing and reimbursement mechanisms used in other countries are described to assess what an optimal system should entail.

Detalles Bibliográficos
Autores principales: Goldstein, Daniel A., Sarfaty, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Value in Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978557/
https://www.ncbi.nlm.nih.gov/pubmed/27384235
http://dx.doi.org/10.1634/theoncologist.2016-0106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978557/
https://www.ncbi.nlm.nih.gov/pubmed/27384235
http://dx.doi.org/10.1634/theoncologist.2016-0106

Ejemplares similares